Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized placebo-controlled study of metformin in myotonic dystrophy type 1
2013-001732-21Phase 2Completed
- Sponsor
- Centre d'Etude des Cellules Souches
- Start
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myotonic dystrophy type 1 (DM1) comparing Metformin with Placebo (2 arms). Primary endpoint: Change from baseline in 6-minute walk test distance. Started Feb 2014; status: completed.
02
Drugs
metformin
03
Conditions
myotonic dystrophy type 1 (DM1)
Beyond the preview
Go deeper on 2013-001732-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001732-21.